Hyper-CVAD/rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyper-CVAD/rituximab, covering 2014-07-21 to 2014-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma [Phase 2]